公开(公告)号：US10124055B2

公开(公告)日：2018-11-13

申请号：US15674585

申请日：2017-08-11

Applicant: ModernaTX, Inc.

Inventor： Giuseppe Ciaramella ,  Sunny Himansu ,  Eric Yi-Chun Huang ,  Tal Zaks

IPC: A61K39/12 ,  A61K9/00 ,  A61K9/127 ,  A61K39/39 ,  A61K39/42 ,  A61K48/00 ,  A61K9/51 ,  A61K39/015 ,  A61K39/00

Abstract: The disclosure relates to Zika virus infection and the treatment thereof. The invention includes ribonucleic acid compositions, as well as methods of using the compositions for treating and preventing Zika virus infection.

公开(公告)号：US20170340724A1

公开(公告)日：2017-11-30

申请号：US15674585

申请日：2017-08-11

Applicant: ModernaTX, Inc.

Inventor： Giuseppe Ciaramella ,  Sunny Himansu ,  Eric Yi-Chun Huang ,  Tal Zaks

IPC: A61K39/12 ,  A61K39/39 ,  A61K39/42 ,  A61K39/00

CPC classification number: A61K39/12 ,  A61K9/0019 ,  A61K9/1271 ,  A61K9/513 ,  A61K39/015 ,  A61K39/39 ,  A61K39/42 ,  A61K2039/51 ,  A61K2039/5254 ,  A61K2039/53 ,  A61K2039/55511 ,  A61K2039/55555 ,  A61K2039/575 ,  C12N2770/24034 ,  C12N2770/24134 ,  C12N2770/36134

Abstract: The disclosure relates to tropical diseases such as viral mosquito borne illnesses and the treatment thereof. The invention includes ribonucleic acid vaccines and combination vaccines, as well as methods of using the vaccines and compositions comprising the vaccines for treating and preventing tropical disease.